K153573 is an FDA 510(k) clearance for the Converge. Classified as Plate, Fixation, Bone within the HRS classification (a category comprising bone fixation plates and orthopedic hardware), Class II - Special Controls.
Submitted by Biomedical Enterprises, Inc. (San Antonio, US). The FDA issued a Cleared decision on August 11, 2016 after a review of 240 days - an extended review cycle.
This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3030 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.
View all Biomedical Enterprises, Inc. devices